[go: up one dir, main page]

An et al., 2022 - Google Patents

Membrane fixation enhances guided bone regeneration in standardized calvarial defects: a pre‐clinical study

An et al., 2022

View PDF
Document ID
17885238840687993598
Author
An Y
Strauss F
Park J
Shen Y
Thoma D
Lee J
Publication year
Publication venue
Journal of Clinical Periodontology

External Links

Snippet

Aim To determine whether collagen membrane (CM) fixation enhances guided bone regeneration in standardized defects. Materials and Methods Four 8‐mm‐diameter defects were surgically made in eight rabbit calvaria, and randomly allocated into four groups …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
An et al. Membrane fixation enhances guided bone regeneration in standardized calvarial defects: a pre‐clinical study
Schwarz et al. Bone regeneration in dehiscence‐type defects at non‐submerged and submerged chemically modified (SLActive®) and conventional SLA titanium implants: an immunohistochemical study in dogs
Hou et al. Comparative study between coral‐mesenchymal stem cells‐rhBMP‐2 composite and auto‐bone‐graft in rabbit critical‐sized cranial defect model
Choi et al. Sinus augmentation using absorbable collagen sponge loaded with Escherichia coli‐expressed recombinant human bone morphogenetic protein 2 in a standardized rabbit sinus model: a radiographic and histologic analysis
Jung et al. Guided bone regeneration with a synthetic biodegradable membrane: a comparative study in dogs
Helder et al. Evaluation of a new biphasic calcium phosphate for maxillary sinus floor elevation: Micro‐CT and histomorphometrical analyses
Ezirganlı et al. The effect of local simvastatin application on critical size defects in the diabetic rats
Schliephake et al. Functionalization of titanium implants using a modular system for binding and release of VEGF enhances bone‐implant contact in a rodent model
Bizenjima et al. Effect of poly (lactide‐co‐glycolide)(PLGA)‐coated beta‐tricalcium phosphate on the healing of rat calvarial bone defects: a comparative study with pure‐phase beta‐tricalcium phosphate
Kim et al. Bone formation in grafts with bio‐Oss and autogenous bone at different proportions in rabbit calvaria
Omar et al. Tissue dynamics and regenerative outcome in two resorbable non‐cross‐linked collagen membranes for guided bone regeneration: A preclinical molecular and histological study in vivo
Sun et al. Bone regeneration of peri‐implant defects using a collagen membrane as a carrier for recombinant human bone morphogenetic protein‐2
Budiatin et al. Bovine Hydroxyapatite‐Based Bone Scaffold with Gentamicin Accelerates Vascularization and Remodeling of Bone Defect
Jung et al. Simultaneous lateral bone augmentation and implant placement using a particulated synthetic bone substitute around chronic peri‐implant dehiscence defects in dogs
Thoma et al. Bone augmentation at peri‐implant dehiscence defects comparing a synthetic polyethylene glycol hydrogel matrix vs. standard guided bone regeneration techniques
Fujioka‐Kobayashi et al. Superior bone‐inducing potential of rhBMP9 compared to rhBMP2
Shin et al. The effects of Erh BMP‐2‐/EGCG‐coated BCP bone substitute on dehiscence around dental implants in dogs
Kuchler et al. Dimethyloxalylglycine lyophilized onto bone substitutes increase vessel area in rat calvarial defects
Choi et al. A laminin‐211‐derived bioactive peptide promotes the osseointegration of a sandblasted, large‐grit, acid‐etched titanium implant
Thoma et al. Bone augmentation using a synthetic hydroxyapatite/silica oxide‐based and a xenogenic hydroxyapatite‐based bone substitute materials with and without recombinant human bone morphogenetic protein‐2
Lee et al. Lateral onlay grafting using different combinations of soft‐type synthetic block grafts and resorbable collagen membranes: An experimental in vivo study
Schwarz et al. Initial pattern of angiogenesis and bone formation following lateral ridge augmentation using rhPDGF and guided bone regeneration: an immunohistochemical study in dogs
Jun et al. Improvement of osseointegration by ultraviolet and/or simvastatin treatment on titanium implants with or without bone graft materials
van de Ven et al. Sustained release of ancillary amounts of testosterone and alendronate from PLGA coated pericard membranes and implants to improve bone healing
Kämmerer et al. Influence of platelet‐derived growth factor on osseous remodeling properties of a variable‐thread tapered dental implant in vivo